Despite limited genomic diversity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has shown a wide range of clinical manifestations in different patient populations. …

In spite of their successes against hematologic malignancies, immunotherapeutic interventions
for the treatment of patients with glioblastoma (GBM) have thus far been unsuccessful. …

RNA viruses that replicate in the cytoplasm often disrupt nucleocytoplasmic transport to
preferentially translate their own transcripts and prevent host antiviral responses. The …

Background Diffuse intrinsic pontine glioma (DIPG) is a uniformly fatal CNS tumor diagnosed
in 300 American children per year. Radiation is the only effective treatment and extends …

SARS-CoV-2 has caused a global pandemic of COVID-19 since its emergence in December
2019. The infection causes a severe acute respiratory syndrome and may also spread to …

The emergence of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2),
the etiological agent of the 2019 coronavirus disease (COVID-19), has erupted into a global …

Therapeutic options against SARS-CoV-2 are underutilized. Two oral drugs, molnupiravir
and paxlovid (nirmatrelvir/ritonavir), have received emergency use authorization. Initial trials …

The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
gravely affected societies around the world. Outbreaks in different parts of the globe have been …

In spite of its immutable susceptibility to penicillin, Treponema pallidum (T. pallidum) subsp.
pallidum continues to cause millions of cases of syphilis each year worldwide, resulting in …

Background Though currently approved immunotherapies, including chimeric antigen
receptor T cells and checkpoint blockade antibodies, have been successfully used to treat …